Document Detail


Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C.
MedLine Citation:
PMID:  7513149     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hepatitis C virus (HCV) is a major cause of acute and chronic hepatitis and cirrhosis worldwide. Screening volunteer donors for antibody to HCV (anti-HCV) has reduced the risk of posttransfusion hepatitis C to less than 1.0% per recipient. Virtually all persons with acute HCV infection seem to become chronically infected, and an average of 67% acquire chronic liver disease with persistently elevated liver enzyme values. Among anti-HCV-positive blood donors, 70% to 90% are HCV RNA positive, but less than half have biochemical evidence of liver disease. The extraordinarily high rate of persistent infection observed in humans and the lack of protection against rechallenge with homologous HCV strains demonstrated in experimental studies in chimpanzees suggest that HCV fails to induce an effective neutralizing antibody response. This raises major concerns for the development of effective passive or active immunoprophylaxis against hepatitis C.
Authors:
M J Alter
Related Documents :
15330909 - Hepatitis c knowledge among primary care residents: is our teaching adequate for the ti...
18414709 - Publicly funded pegylated interferon-alpha treatment in british columbia: disparities i...
25348459 - Implementing comprehensive prevention of mother-to-child transmission and hiv preventio...
10622599 - Perspectives for a vaccine against hepatitis c virus.
25446339 - Nanotech-derived topical microbicides for hiv prevention: the road to clinical developm...
22107359 - Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among h...
22177559 - Peptides released by physiological cleavage of semen coagulum proteins form amyloids th...
1955309 - The prevalence and interaction of human immunodeficiency virus and hepatitis b virus in...
20453819 - Increasing access to hiv counseling and testing through mobile services in kenya: strat...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Archives of pathology & laboratory medicine     Volume:  118     ISSN:  0003-9985     ISO Abbreviation:  Arch. Pathol. Lab. Med.     Publication Date:  1994 Apr 
Date Detail:
Created Date:  1994-05-25     Completed Date:  1994-05-25     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7607091     Medline TA:  Arch Pathol Lab Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  342-5     Citation Subset:  AIM; IM    
Affiliation:
Hepatitis Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Donors
Blood Transfusion / adverse effects*
Hepacivirus / immunology*
Hepatitis Antibodies / blood*
Hepatitis C / diagnosis*,  etiology
Hepatitis C Antibodies
Humans
Risk
Serologic Tests
Chemical
Reg. No./Substance:
0/Hepatitis Antibodies; 0/Hepatitis C Antibodies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Omentopexy for tracheal autografts.
Next Document:  Temporal regulation of the IgE-dependent 1,2-diacylglycerol production by tyrosine kinase activation...